Alumis ALMS
NASDAQ ALMS
$7.21 -0.18 (-2.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alumis (ALMS) Net Margin (2025 - 2026)

Updated

Alumis (ALMS) reported Net Margin of -8557.22% for Q2 2026, down 10782.31 percentage points from 2225.09% a year earlier.

Analysis

Alumis (ALMS) Net Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alumis' Net Margin came in at -3443.77%; for FY2025, it was -1011.75%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Alumis 919.65 Mn -755.19 Mn - -8,557.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,557.22%
Dec 31, 2025 -4,817.26%
Sep 30, 2025 -5,363.02%
Jun 30, 2025 2,225.09%
Mar 31, 2025 -568.75%
API Access

Alumis Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY